Loading...

Towards personalized therapy for patients with glioblastoma

Combined therapy with temozolomide and radiotherapy is a standard treatment and improves the survival for patients with newly diagnosed glioblastoma. However, the prognosis remains poor, with a median survival time of 12–15 months. Currently, several clinical trials of dose-dense temozolomide regime...

Full description

Saved in:
Bibliographic Details
Published in:Expert Rev Anticancer Ther
Main Authors: Shirai, Katsuyuki, Chakravarti, Arnab
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297206/
https://ncbi.nlm.nih.gov/pubmed/22117160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.11.103
Tags: Add Tag
No Tags, Be the first to tag this record!